NPPA fixes retail prices of 14 formulations, check out details

Published On 2018-03-01 09:12 GMT   |   Update On 2018-03-01 09:12 GMT

New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has fixed the retail prices of 14 formulations under the Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST).


The notice states that in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O. 701(E) dated 10th March 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;


Following are the details







































































































































Sl. NoName of the
Formulation / Brand Name
StrengthUnitManufacturer & Marketing CompanyRetail Price (Rs.)
(1) (2) (3) (4) (5)(6)
1Amlodipine +,
Valsartan Tablet (Valembic 80 AM)
Each film coated tablet contains:
Amlodipine Besylate eq. to Amlodipine
USP 5mg,
Valsartan USP 80mg Tablet
1 TabletM/s Vapicare pharma Pvt.
Ltd. / M/s Alembic
Pharmaceuticals Limited
2.10
2Amlodipine +,
Valsartan Tablet
(Valembic 160 AM)
Each film coated tablet contains:
Amlodipine Besylate eq. to Amlodipine USP 5mg,
Valsartan USP 160mg Tablet
1 TabletM/s Vapicare pharma Pvt.
Ltd. / M/s Alembic
Pharmaceuticals Limited
3.24
3Paclitaxel (Protein
Bound Particles) for
Injectable Suspension
(Nabtoxol)
Each vial contains: Paclitaxel 100mg Human albumin1 VialM/s Panacea Biotec Ltd. /
M/s Mylan
Pharmaceuticals Pvt. Ltd.
11115.39
4Telmisartan +
Chlorthalidone Tablet
Each uncoated bilayered tablet contains:
Telmisartan IP 40mg,
Chlorthalidone IP 6.25mg
1 TabletM/s Akums Drugs &
Pharmaceuticals Ltd. / M/s Mankind Pharma
Limited
7.41
5Glimepiride +
Metformin +
Voglibose Tablet
(TRIVOGO 2/0.3 Mg)
Each uncoated bilayered tablet
contains:
Glimepiride IP 2mg,
Metformin Hydrochloride IP 500mg
(As SR form)
Voglibose IP 0.3mg
1 TabletM/s Windlas Biotech
Limited / M/s Alembic
Pharmaceuticals Ltd.
9.39
6Etoricoxib +
Paracetamol Tablet
Each film coated tablet contains:
Etoricoxib IP 60mg , Paracetamol IP 325mg
1 TabletM/s Ravenbhel Healthcare
Pvt. Ltd. / M/s Abbott
Healthcare Pvt. Ltd.
5.14
7Sofosbuvir +
Velpatasvir Tablets
Each film coated tablet contains:
Sofosbuvir IH 400mg,
Velpatasvir IH 100mg
28’s
Tablets
M/s Hetero Labs Ltd. /
M/s Torrent
Pharmaceuticals Ltd.
15625.00
8Atorvastatin +
Clopidogrel Capsule
Each hard gelatine capsule contains:
Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As Pellets)
Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As Pellets)
1 CapsuleM/s Synokem
Pharmaceuticals Ltd. /
M/s Emcure
Pharmaceuticals Limited
8.394
9Atorvastatin +
Clopidogrel Capsule
Each hard gelatine capsule contains:
Atorvastatin Calcium IP eq. to Atorvastatin 20mg (As Pellets)
Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As Pellets)
1 CapsuleM/s Synokem
Pharmaceuticals Ltd. / M/s Emcure
Pharmaceuticals Limited
10.596
10Rosuvastatin +
Aspirin +
Clopidogrel Capsule
Each hard gelatine capsule contains:
Rosuvastatin Calcium IP eq. to Rosuvastation 20mg (As pellets)
Aspirin IP 75mg (As enteric coated
pellets)
Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As pellets)
1 CapsuleM/s Synokem
Pharmaceuticals Ltd../
M/s Intas
Pharmaceuticals Limited
18.00
11Ferrous Ascorbate +
Folic Acid Suspension
Each 5ml of suspension contains:
Ferrous Ascorbate eq. to elemental
Iron 30mg,
Folic Acid IP 550mcg In a flavoured
Syrupy base.
1 MLM/s Innova Captab Pvt.
Ltd. / M/s Intas
Pharmaceuticals Limited
0.647
12Bortezomib InjectionEach vial contains:
Bortezomib IP 3.5mg Injection
1 VialM/s Intas
Pharmaceuticals Limited
12500.00
13Teneligliptin +
Metformin HCl Tablet
Each uncoated bilayered tablet
contains:
Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg
Metformin HCl 500mg (SR)
1 TabletM/s Windlas Biotech
Limited and marketed by
M/s Abbott India Limited
9.62
14Teneligliptin +
Metformin HCl Tablet
Each uncoated bilayered tablet
contains:
Teneligliptin Hydrobromide Hydrate
eq. to Teneligliptin 20mg
Metformin HCl 1000mg (SR)
1 TabletM/s Windlas Biotech
Limited and marketed by
M/s Abbott India Limited
10.87


The manufacturers of above said scheduled formulations shall furnish a quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations in Form – III of Schedule – II of the DPCO, 2013 through IPDMS.


Any manufacturer intending to discontinue production of said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form -IV of Schedule – II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.


The manufacturers not complying with the ceiling price and notes specified shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.


Consequent to the issue of ceiling prices of such formulations as specified, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.


Below is the attachment for the same.


http://www.nppaindia.nic.in/ceiling/press27feb18/Formulation_Prices(14).pdf


Medical Dialogues had earlier reported that NPPA had fixed the ceiling prices of 09 formulations under the Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST).


Read also: 9 more formulations including Methylprednisolone Inj under Price Ceiling: NPPA order

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News